Aflac Q1 revenues rise 28%, net earnings soar to $1B, driven by strong product sales and strategic growth.

Aflac reported a 27.9% increase in first-quarter revenues to $4.3 billion and a significant jump in net earnings to $1.0 billion, or $1.98 per diluted share, compared to $29 million a year ago. Adjusted earnings remained stable at $901 million, with a 5.4% rise in adjusted earnings per share to $1.75. Growth was supported by new product sales in Japan and the U.S., including medical, cancer, and life insurance products, alongside a $1.3 billion return to shareholders through buybacks and dividends. The company aims to continue balancing profitable growth with capital deployment while maintaining its long-standing dividend increase record.